|Bid||3.15 x 2000|
|Ask||3.75 x 400|
|Day's Range||3.25 - 3.50|
|52 Week Range||2.10 - 4.45|
|PE Ratio (TTM)||-1.40|
|Earnings Date||Aug 8, 2017 - Aug 14, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||76.00|
SAN DIEGO, May 31, 2017-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's ...
-Poster Presentations to Explore Potential of Augmenting Resokine Pathway in Severe, Rare Pulmonary Diseases with an Immune or Fibrotic Component-. -Conference Call and Webcast Featuring Guest Speaker ...
The San Diego-based company said it had a loss of 56 cents per share. In the final minutes of trading on Thursday, the company's shares hit $3.10. A year ago, they were trading at $3.01. _____ This story ...